Cargando…
Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation
Visceral leishmaniasis (VL) is a neglected tropical disease that causes substantial morbidity and mortality and is a growing health problem in Ethiopia, where this study took place. Most individuals infected with Leishmania donovani parasites will stay asymptomatic, but some develop VL that, if left...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262188/ https://www.ncbi.nlm.nih.gov/pubmed/35749568 http://dx.doi.org/10.1371/journal.pntd.0010544 |
_version_ | 1784742435998400512 |
---|---|
author | Takele, Yegnasew Adem, Emebet Franssen, Susanne Ursula Womersley, Rebecca Kaforou, Myrsini Levin, Michael Müller, Ingrid Cotton, James Anthony Kropf, Pascale |
author_facet | Takele, Yegnasew Adem, Emebet Franssen, Susanne Ursula Womersley, Rebecca Kaforou, Myrsini Levin, Michael Müller, Ingrid Cotton, James Anthony Kropf, Pascale |
author_sort | Takele, Yegnasew |
collection | PubMed |
description | Visceral leishmaniasis (VL) is a neglected tropical disease that causes substantial morbidity and mortality and is a growing health problem in Ethiopia, where this study took place. Most individuals infected with Leishmania donovani parasites will stay asymptomatic, but some develop VL that, if left untreated, is almost always fatal. This stage of the disease is associated with a profound immunosuppression, characterised by impaired production of Interferonγ (IFNγ), a cytokine that plays a key role in the control of Leishmania parasites, and high expression levels of an inhibitory receptor, programmed cell death 1 (PD1) on CD4(+) T cells. Here, we tested the contribution of the interaction between the immune checkpoint PD1 and its ligand PDL-1 on the impaired production of IFNγ in VL patients. Our results show that in the blood of VL patients, not only CD4(+), but also CD8(+) T cells express high levels of PD1 at the time of VL diagnosis. Next, we identified PDL-1 expression on different monocyte subsets and neutrophils and show that PDL-1 levels were significantly increased in VL patients. PD1/PDL-1 inhibition resulted in significantly increased production of IFNγ, suggesting that therapy using immune checkpoint inhibitors might improve disease control in these patients. |
format | Online Article Text |
id | pubmed-9262188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-92621882022-07-08 Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation Takele, Yegnasew Adem, Emebet Franssen, Susanne Ursula Womersley, Rebecca Kaforou, Myrsini Levin, Michael Müller, Ingrid Cotton, James Anthony Kropf, Pascale PLoS Negl Trop Dis Research Article Visceral leishmaniasis (VL) is a neglected tropical disease that causes substantial morbidity and mortality and is a growing health problem in Ethiopia, where this study took place. Most individuals infected with Leishmania donovani parasites will stay asymptomatic, but some develop VL that, if left untreated, is almost always fatal. This stage of the disease is associated with a profound immunosuppression, characterised by impaired production of Interferonγ (IFNγ), a cytokine that plays a key role in the control of Leishmania parasites, and high expression levels of an inhibitory receptor, programmed cell death 1 (PD1) on CD4(+) T cells. Here, we tested the contribution of the interaction between the immune checkpoint PD1 and its ligand PDL-1 on the impaired production of IFNγ in VL patients. Our results show that in the blood of VL patients, not only CD4(+), but also CD8(+) T cells express high levels of PD1 at the time of VL diagnosis. Next, we identified PDL-1 expression on different monocyte subsets and neutrophils and show that PDL-1 levels were significantly increased in VL patients. PD1/PDL-1 inhibition resulted in significantly increased production of IFNγ, suggesting that therapy using immune checkpoint inhibitors might improve disease control in these patients. Public Library of Science 2022-06-24 /pmc/articles/PMC9262188/ /pubmed/35749568 http://dx.doi.org/10.1371/journal.pntd.0010544 Text en © 2022 Takele et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Takele, Yegnasew Adem, Emebet Franssen, Susanne Ursula Womersley, Rebecca Kaforou, Myrsini Levin, Michael Müller, Ingrid Cotton, James Anthony Kropf, Pascale Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation |
title | Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation |
title_full | Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation |
title_fullStr | Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation |
title_full_unstemmed | Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation |
title_short | Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation |
title_sort | impaired in vitro interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of pd1/pdl-1 ligation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262188/ https://www.ncbi.nlm.nih.gov/pubmed/35749568 http://dx.doi.org/10.1371/journal.pntd.0010544 |
work_keys_str_mv | AT takeleyegnasew impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation AT adememebet impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation AT franssensusanneursula impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation AT womersleyrebecca impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation AT kaforoumyrsini impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation AT levinmichael impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation AT mulleringrid impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation AT cottonjamesanthony impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation AT kropfpascale impairedinvitrointerferongproductioninpatientswithvisceralleishmaniasisisimprovedbyinhibitionofpd1pdl1ligation |